The novel approach of tirzepatide peptide represents a major development in the care of type 2 diabetes. Different to existing medications, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide264063.is-blog.com/48981539/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment